Xanthinol nicotinate induced bullous drug eruption
References
Sean CS. In: Nutritional agents and vitamins. Martindale-The complete drug reference, 35th ed. Pharmaceutical press, London; 2007; Page1762-1836.
American society of Health-System Pharmacists. ASHP therapeutic position statement on the safe use of niacin in the management of dyslipidemias. Am J Health Syst Pharm 1997; 54: 2815-19.
Lavie CJ, Milani RV. Safety and side-effects of sustained release niacin. JAMA 1994; 272: 513-14.
Khan SA, Rodrigues G, Rao PGM. Nicotinic acid derivative induced bullous eruption. Int J Risk Safety Med 2006; 18: 159-62,
Downloads
Published
2016-12-24
How to Cite
1.
Mehta V, Vasanth V, Balachandran C. Xanthinol nicotinate induced bullous drug eruption. J Pak Assoc Dermatol [Internet]. 2016Dec.24 [cited 2025Nov.13];19(2):124-5. Available from: http://jpad.com.pk/index.php/jpad/article/view/526
Issue
Section
Short Communications
